Sponsor

Aerovance, Inc.

Clinical research sponsor

Published trials4

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

4 shown

A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIALNCT00801853 · lead sponsor · 2009-03-01

COMPLETED

A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic SubjectsNCT00785668 · lead sponsor · 2007-11-01

COMPLETED

Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic AsthmaticsNCT00535431 · lead sponsor · 2005-12-01

COMPLETED

A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)NCT00535028 · lead sponsor · 2005-01-01

COMPLETED

Sponsor roles

lead sponsor4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.